In the Wamo-Dyne Catalogue, a "Grainger"-like catalogue that specializes in laboratory equipment, the list price of the much needed Guanine-Adenine-Thymine-Cytosine Nucleotide Splicer, Model XJ 5000 is $75,000. You're an engineer working for a genome-altering biometrics firm and you're in charge of the purchase. However, you're faced with a dilemma: You can buy the equipment directly from GeneSplicers, Inc. (the manufacturer), but you can't afford the list price. But not to worry, GeneSplicers, Inc. is offering financing at 8% with annual payments for four (4) years and only requires a down payment of $25,000. Alternatively, Hank, the friendly hometown salesman who works for Wamo-Dyne, is offering to sell the equipment for a 10% price reduction from list price if you pay cash today. Your management is asking you to defend your decision three waysthey don't care which financial analyses you choose, but they want to see three different methods. With human lives on the line in desperate need of some nucleotide splicing, which alternative will you recommend?